ConductScience.org, home

Paper36768977

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.

Tian LY and 2 others. Int J Mol Sci, 2023. Cited by 295 papers, by iCite.

Cite this record

ConductScience Library. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Papers, record 36768977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768977

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
295
iCite
Relative citation ratio, by iCite
32.5
iCite
Revised in PubMed
2023-02-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian LYLing-Yu
2Smit DJDaniel Jhttps://orcid.org/0000-0002-3190-9511
3Jücker MManfredhttps://orcid.org/0000-0003-2176-6526

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Humans
Proto-Oncogene Proteins c-akt
Phosphatidylinositol 3-Kinases
Cell Line, Tumor
Signal Transduction
TOR Serine-Threonine Kinases

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
202106010223China Scholarship CouncilPubMed

Source PubMed

Download CSV of grants

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132681102A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes.Cell Death Dis2020https://conductscience.org/library/papers/32681102PubMed
221233853Metabolism, migration and memory in cytotoxic T cells.Nat Rev Immunol2011https://conductscience.org/library/papers/21233853PubMed
335276232Metabolic tricks of cancer cells.Biochim Biophys Acta Rev Cancer2022https://conductscience.org/library/papers/35276232PubMed
435169125UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.Cell Death Dis2022https://conductscience.org/library/papers/35169125PubMed
525492937Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells.J Leukoc Biol2015https://conductscience.org/library/papers/25492937PubMed
634123854Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.Front Oncol2021https://conductscience.org/library/papers/34123854PubMed
726321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed
830312701Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis.Life Sci2018https://conductscience.org/library/papers/30312701PubMed
925533673PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.Nat Rev Cancer2015https://conductscience.org/library/papers/25533673PubMed
1032738450p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.J Hepatol2021https://conductscience.org/library/papers/32738450PubMed
1121128229Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.Int J Cancer2011https://conductscience.org/library/papers/21128229PubMed
1224981175Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis.Mol Cell2014https://conductscience.org/library/papers/24981175PubMed
1332934330Exploring the NK cell platform for cancer immunotherapy.Nat Rev Clin Oncol2021https://conductscience.org/library/papers/32934330PubMed
1434433044Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer.Cell Rep2021https://conductscience.org/library/papers/34433044PubMed
1532070029Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32070029PubMed
1618473854Arginine deprivation as a targeted therapy for cancer.Curr Pharm Des2008https://conductscience.org/library/papers/18473854PubMed
1730809309LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.Theranostics2019https://conductscience.org/library/papers/30809309PubMed
1826629311Targeting amino acid metabolism in cancer growth and anti-tumor immune response.World J Biol Chem2015https://conductscience.org/library/papers/26629311PubMed
1931387985Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma.Oncogenesis2019https://conductscience.org/library/papers/31387985PubMed
2024055031A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/24055031PubMed

See all 152 referencesDownload CSV of references

Cited by222

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.

PMIDTitleJournalYearIn PapersSource
42978971Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/42978971PubMed
42940018Copper Nanoparticles at Optimized Concentrations Exhibit Minimal Intrinsic Biological Effects in Hepatocellular Carcinoma Cells.Biomedicines2026https://conductscience.org/library/papers/42940018PubMed
42939944Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling.Biomedicines2026https://conductscience.org/library/papers/42939944PubMed
42890543The dual IGF-1R/IR blocker, Linsitinib, modulates human orbital fibroblast activity and proliferation.Front Immunol2026https://conductscience.org/library/papers/42890543PubMed
42858308Tissue-Specific Isolation of Hepatocyte Extracellular Vesicles From Human Plasma Enables Tissue-Resolved Proteomic and miRNA Profiling.J Extracell Vesicles2026https://conductscience.org/library/papers/42858308PubMed
42799406Understanding the Potential of Antibody-Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review.Health Sci Rep2026https://conductscience.org/library/papers/42799406PubMed
42793207Rethinking Drug Resistance in Acute Promyelocytic Leukemia: The Regulated Cell Death Network as an Integrative Framework.Biomolecules2026https://conductscience.org/library/papers/42793207PubMed
42792873Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells.Biomedicines2026https://conductscience.org/library/papers/42792873PubMed
42792787Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma.Biomedicines2026https://conductscience.org/library/papers/42792787PubMed
42769963Immune cell-derived exosomes in cancer: double-edged mechanisms of antitumor immunity and tumor progression.Front Immunol2026https://conductscience.org/library/papers/42769963PubMed
42747623Amino acid transporters in hepatocellular carcinoma: Gatekeepers of metabolic reprogramming.Mol Biol Rep2026https://conductscience.org/library/papers/42747623PubMed
42739743Comparison of the Effects of Sorafenib and Stem Cell Secretome on HepG2 Cancer Cells with Respect to the Ras/Raf/MEK/ERK Pathway.J Clin Med2026https://conductscience.org/library/papers/42739743PubMed
42726806Identification of functional genes and immune cell infiltration analysis in liposarcoma.PLoS One2026https://conductscience.org/library/papers/42726806PubMed
42724077Lipid Metabolism-related lncRNA Model Identifies AC026412.3 as a Driver of Fatty Acid β-oxidation in Hepatocellular Carcinoma.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42724077PubMed
42667530Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges.Med Oncol2026https://conductscience.org/library/papers/42667530PubMed
42653240Single-Cell Analysis Reveals STARD10 as a Fatty Acid Metabolism Regulator of Breast Cancer Progression via the PI3K/Akt Pathway.Int J Mol Sci2026https://conductscience.org/library/papers/42653240PubMed
42652115Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies.Biomedicines2026https://conductscience.org/library/papers/42652115PubMed
42634207Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights.J Cell Mol Med2026https://conductscience.org/library/papers/42634207PubMed
42619501Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Nanomedicine (Lond)2026https://conductscience.org/library/papers/42619501PubMed
42587233Size-Dependent Differences in the Effects of Low-Dose Selenium Nanoparticles on Chronic Thioacetamide Toxicosis Accompanying HCC Progression in Mice.Biol Trace Elem Res2026https://conductscience.org/library/papers/42587233PubMed

See all 222 cited byDownload CSV of cited by

Genes74

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
ACOD1730249PubTator's text mininghttps://conductscience.org/library/genes/730249NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
AKT310000PubTator's text mininghttps://conductscience.org/library/genes/10000NCBI Gene
AREG374PubTator's text mininghttps://conductscience.org/library/genes/374NCBI Gene
ASNS440PubTator's text mininghttps://conductscience.org/library/genes/440NCBI Gene
BSG682PubTator's text mininghttps://conductscience.org/library/genes/682NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
DHODH1723PubTator's text mininghttps://conductscience.org/library/genes/1723NCBI Gene
E2F11869PubTator's text mininghttps://conductscience.org/library/genes/1869NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EIF4EBP11978PubTator's text mininghttps://conductscience.org/library/genes/1978NCBI Gene
FASN2194PubTator's text mininghttps://conductscience.org/library/genes/2194NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene
GLUD12746PubTator's text mininghttps://conductscience.org/library/genes/2746NCBI Gene
GLUL2752PubTator's text mininghttps://conductscience.org/library/genes/2752NCBI Gene

See all 74 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768977

GET https://conductscience.org/api/papers/v1/36768977/references?page=2